Closing

1D

YTD

Market cap

-

52 week high

-

52 week low

-

Volume

-

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

-

Analysts' Rating

-

Price Target (Mean)

-

Total Analysts

0

P/E

-

Operating Margin

-

Beta

-

Revenue Growth (Annual)

-

52 week high

-

52 week low

-

Div. Yield

-

EPS Annual Growth

-

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Eureking SA is a France-based special purpose acquisition company (SPAC) formed with the aim of acquiring targets companies in the field of pharmaceutical industry. The Company intends to the European and fast-growing companies specializing in three business segments: the production of biological products, cell and gene therapies and live Biotherapeutics (with applications in the microbiome). The Biotherapies and technological solutions in the Biopharmaceutical companies are used to develop new treatments with both logistical and industrial support along with the tools and production capacity to pursue the clinical developments or to market the products.